Volume 80, Issue 4, Pages (August 2011)

Slides:



Advertisements
Similar presentations
Volume 74, Issue 2, Pages (July 2008)
Advertisements

Volume 66, Issue 2, Pages (August 2004)
Volume 55, Issue 4, Pages (April 1999)
Volume 81, Issue 11, Pages (June 2012)
Metabolomic study of cisplatin-induced nephrotoxicity
Animal models of urinary stone disease
An active renal crystal clearance mechanism in rat and man
Volume 3, Issue 2, Pages (August 2017)
Volume 67, Issue 1, Pages (January 2005)
Volume 61, Issue 3, Pages (March 2002)
Volume 199, Issue 1, Pages (January 2018)
A. Evan, J. Lingeman, F.L. Coe, E. Worcester  Kidney International 
Saeed R. Khan, Patricia A. Glenton, Renal Backov, Daniel R. Talham 
Volume 78, Issue 3, Pages (August 2010)
Volume 74, Issue 2, Pages (July 2008)
The Case ∣ Acute renal failure and anemia
Ming-Tso Yan, Ming-Ju Wu, Po-Jen Hsaio, Shih-Hua Lin 
Volume 69, Issue 12, Pages (June 2006)
Driving change: kidney proximal tubule CSF-1 polarizes macrophages
Volume 84, Issue 1, Pages (July 2013)
Volume 66, Issue 3, Pages (September 2004)
Volume 55, Issue 2, Pages (February 1999)
Sialic acid-containing glycoproteins on renal cells determine nucleation of calcium oxalate dihydrate crystals  John C. Lieske, M.D., F. Gary Toback,
Vitamin E attenuates crystal formation in rat kidneys: Roles of renal tubular cell death and crystallization inhibitors  H.-S. Huang, J. Chen, C.-F. Chen,
Volume 76, Issue 10, Pages (November 2009)
Phulwinder K Grover, Villis R Marshall, Rosemary L Ryall 
Volume 84, Issue 5, Pages (November 2013)
Volume 71, Issue 8, Pages (April 2007)
Volume 79, Issue 5, Pages (March 2011)
Lead Transformation to Pyromorphite by Fungi
Response to ‘Active renal crystal clearance in rats and humans’
Volume 121, Issue 6, (December 2001)
Hsin-Hui Wang, Tzong-Yann Lee, Ching-Yuang Lin  Kidney International 
Volume 66, Issue 2, Pages (August 2004)
Volume 86, Issue 6, Pages (December 2014)
Methotrexate in the urine
Comorbidity and confounding in end-stage renal disease
Volume 74, Issue 3, Pages (August 2008)
The new role of calcimimetics as vasculotropic agents
Comparative effects of potassium chloride and bicarbonate on thiazide-induced reduction in urinary calcium excretion  Lynda A. Frassetto, Eileen Nash,
Volume 87, Issue 3, Pages (March 2015)
Volume 72, Issue 3, Pages (August 2007)
Volume 86, Issue 2, Pages (August 2014)
Volume 87, Issue 2, Pages (February 2015)
Acute oxalate nephropathy due to ethylene glycol ingestion
Drosophila: a fruitful model for calcium oxalate nephrolithiasis?
Volume 56, Issue 3, Pages (September 1999)
Kenar D. Jhaveri, Steven Fishbane  Kidney International 
Ring-like calcifications of the kidney
The pathological role of Bax in cisplatin nephrotoxicity
Prevention of biofilm formation in dialysis water treatment systems
Dual roles of brushite crystals in calcium oxalate crystallization provide physicochemical mechanisms underlying renal stone formation  R. Tang, G.H.
Volume 72, Issue 1, Pages 8-10 (July 2007)
Driving change: kidney proximal tubule CSF-1 polarizes macrophages
John H. Wiessner, Linda Y. Hung, Neil S. Mandel  Kidney International 
Volume 59, Issue 2, Pages (February 2001)
The Case ∣ Metabolic disarray after fire extinguisher powder ingestion
Shree Ram Singh, Wei Liu, Steven X. Hou  Cell Stem Cell 
Nephrology Crossword: Glomerulonephritis
Volume 68, Issue 4, Pages (October 2005)
Volume 55, Issue 4, Pages (April 1999)
Plasma calcium-oxalate saturation in children with renal insufficiency and in children with primary hyperoxaluria  Bernd Hoppe, Markus J. Kemper, Arend.
Volume 53, Issue 4, Pages (April 1998)
Volume 64, Issue 2, Pages (August 2003)
Volume 81, Issue 11, Pages (June 2012)
Quiz Page Answers September 2005
Treatment of the primary hyperoxalurias: A new chapter
Localized bladder amyloidosis mimicking bladder carcinoma
Reappraisal of melamine exposure and adult calcium urolithiasis
Volume 77, Issue 5, Pages (March 2010)
Presentation transcript:

Volume 80, Issue 4, Pages 369-377 (August 2011) Ethylene glycol induces calcium oxalate crystal deposition in Malpighian tubules: a Drosophila model for nephrolithiasis/urolithiasis  Yung-Hsiang Chen, Hsin-Ping Liu, Huey-Yi Chen, Fuu-Jen Tsai, Chiao-Hui Chang, Yuan-Ju Lee, Wei-Yong Lin, Wen-Chi Chen  Kidney International  Volume 80, Issue 4, Pages 369-377 (August 2011) DOI: 10.1038/ki.2011.80 Copyright © 2011 International Society of Nephrology Terms and Conditions

Figure 1 Hyperoxaluria-causing agent-induced calcium oxalate (CaOx) crystal deposition in Malpighian tubules. (a) A drawing of the Malpighian tubules. Drosophila has four tubules; the anterior pair and the posterior pair. Each tubule has distinct morphologic regions: initial, transitional, main segments, and lower tubule. The two tubules in each pair merge together at ureters and connect to the gut at the midgut/hindgut boundary. (b) Representative polarized microscopy photos for ethylene glycol (EG)-, hydroxyl-L-proline (HLP), and sodium oxalate (NaOx)-induced CaOx crystal formations in Malpighian tubules. (c) Monohydrate CaOx crystals and dihydrate CaOx crystals. (d) The different degrees (-, +, ++, and +++) of CaOx crystal deposition in the Malpighian tubules for semiquantification of crystal formation (arbitrarily crystal score: 0=no, 1=weak, 2=moderate, and 3=strong crystal formation). Kidney International 2011 80, 369-377DOI: (10.1038/ki.2011.80) Copyright © 2011 International Society of Nephrology Terms and Conditions

Figure 2 Scanning electron microscopy (SEM) and energy-dispersive X-ray spectroscopy (EDS or EDX) microanalysis for calcium oxalate (CaOx) crystals. Representative SEM images and EDX spectrums of a grain present at the top of Malpighian tubules under ethylene glycol (EG) treatment. After removing Malpighian tubule tissue with lysis buffer, SEM shows internalization view. Surface shows adherence with protruding crystals. EDS spectra were recorded at 20kV. The inset photo shows the polarized microscopy image of the crystal sample, the arrow shows the location where the beam was focused; EDS spectra obtained with the beam focused at points in the crystal sample. The predominant components were found to be carbon (C), oxygen (O), and calcium (Ca). Scale bar=60μm. Kidney International 2011 80, 369-377DOI: (10.1038/ki.2011.80) Copyright © 2011 International Society of Nephrology Terms and Conditions

Figure 3 High-dose hyperoxaluria-causing agents induced Drosophila life-span reduction and increased incidence of crystal formation. (a) Cumulative survival distributions by administration of hyperoxaluria-causing agents ethylene glycol (EG), hydroxyl-L-proline (HLP), and sodium oxalate (NaOx). Flies treated with hyperoxaluria-causing agents showed significant life-span reduction in a dose-dependent manner compared with control (n≅150 for each group, P<0.0001). (b) The relation of mean life span and incidence of calcium oxalate (CaOx) crystal formation in male Drosophila treated with hyperoxaluria-causing agents (n≅100 for each group, *P<0.01 compared with control). In this and the following figures, only male flies were used, with their numbers indicated in parentheses for each experiment. Kidney International 2011 80, 369-377DOI: (10.1038/ki.2011.80) Copyright © 2011 International Society of Nephrology Terms and Conditions

Figure 4 Inhibition of crystal formation and life-span extension by potassium citrate (K-Citrate) treatment. (a) Dose-dependent effects of K-Citrate on 0.5% ethylene glycol (EG)-induced calcium oxalate (CaOx) crystal formation (n≅100 for each group, the results for least eight separate experiments are expressed as mean±s.d. *P<0.001 compared with control; #P<0.001 compared with EG-treated group). (b) Life-span extension of 0.5% EG-treated flies by K-Citrate treatment (n≅150 for each group, P<0.0001). (c) Representative polarized microscopy photos for K-Citrate-remedied CaOx crystal formation in Malpighian tubules. Enlarged photo shows the powdered small crystals in the ‘ureter’ site. (d) Effects of K-Citrate on hydroxyl-L-proline (HLP)- and sodium oxalate (NaOx)-induced crystal formations (n≅100 for each group, the results for least eight separate experiments are expressed as mean±s.d. *P<0.05 compared with control; #P<0.05 compared with HLP or NaOx-treated group); life-span extension of HLP-treated flies by K-Citrate treatment (n≅150 for each group, P<0.05). Kidney International 2011 80, 369-377DOI: (10.1038/ki.2011.80) Copyright © 2011 International Society of Nephrology Terms and Conditions